196 related articles for article (PubMed ID: 24369276)
1. [The setting of the treatment target of osteoporosis].
Soen S
Clin Calcium; 2014 Jan; 24(1):19-24. PubMed ID: 24369276
[TBL] [Abstract][Full Text] [Related]
2. Safety issues with bisphosphonate therapy for osteoporosis.
Suresh E; Pazianas M; Abrahamsen B
Rheumatology (Oxford); 2014 Jan; 53(1):19-31. PubMed ID: 23838024
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.
McClung M; Harris ST; Miller PD; Bauer DC; Davison KS; Dian L; Hanley DA; Kendler DL; Yuen CK; Lewiecki EM
Am J Med; 2013 Jan; 126(1):13-20. PubMed ID: 23177553
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates in the treatment of osteoporosis.
Diab DL; Watts NB
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):487-506. PubMed ID: 22877426
[TBL] [Abstract][Full Text] [Related]
5. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
Hayakawa N; Suzuki A
Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
[TBL] [Abstract][Full Text] [Related]
6. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
Mashiba T
Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
[TBL] [Abstract][Full Text] [Related]
7. [Bone and Calcium Research Update 2015. Therapy of osteoporosis--Now and future consideration of long-term therapy].
Gorai I
Clin Calcium; 2015 Jan; 25(1):105-13. PubMed ID: 25530528
[TBL] [Abstract][Full Text] [Related]
8. Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
Emkey RD; Ettinger M
Am J Med; 2006 Apr; 119(4 Suppl 1):S18-24. PubMed ID: 16563937
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.
Laroche M; Livideanu C; Paul C; Cantagrel A
Am J Med; 2011 Aug; 124(8):776-8. PubMed ID: 21787907
[TBL] [Abstract][Full Text] [Related]
10. [Atypical femoral fractures in long-term osteoporotic treatment with bisphosphonates].
Thein R; Tenenbaum S; Chechick O; Hershkovitz O; Chechik A; Caspi I
Harefuah; 2012 Sep; 151(9):532-6, 555. PubMed ID: 23367748
[TBL] [Abstract][Full Text] [Related]
11. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
Cole RE
Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
[TBL] [Abstract][Full Text] [Related]
12. Current treatment approaches to osteoporosis - 2013.
Honig S; Rajapakse CS; Chang G
Bull Hosp Jt Dis (2013); 2013; 71(3):184-8. PubMed ID: 24151942
[TBL] [Abstract][Full Text] [Related]
13. [Once-weekly teriparatide treatment on osteoporosis].
Nakano T
Clin Calcium; 2014 Jan; 24(1):100-5. PubMed ID: 24369286
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis: an increasing concern in pediatric dentistry.
da Fonseca MA
Pediatr Dent; 2011; 33(3):241-5. PubMed ID: 21703077
[TBL] [Abstract][Full Text] [Related]
15. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
Josse R; Khan A; Ngui D; Shapiro M
Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
[TBL] [Abstract][Full Text] [Related]
16. Role of the Pharmacist in Medication Therapy Management Services in Patients With Osteoporosis.
Murphy-Menezes M
Clin Ther; 2015 Jul; 37(7):1573-86. PubMed ID: 25913920
[TBL] [Abstract][Full Text] [Related]
17. Going on a drug holiday?
Bonnick SL
J Clin Densitom; 2011; 14(4):377-83. PubMed ID: 22051091
[No Abstract] [Full Text] [Related]
18. Osteoporosis: how long should we treat?
Sebba A
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):502-7. PubMed ID: 18971678
[TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy of osteoporosis after the bisphosphonates discontinuation.].
Soen S
Clin Calcium; 2017; 27(2):273-280. PubMed ID: 28123130
[TBL] [Abstract][Full Text] [Related]
20. Fractures in chronic kidney disease: pursuing the best screening and management.
Goldenstein PT; Jamal SA; Moysés RM
Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):317-23. PubMed ID: 26050117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
